GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Shares Buyback Ratio %

LVTX (LAVA Therapeutics NV) Shares Buyback Ratio % : -0.06 (As of May. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. LAVA Therapeutics NV's current shares buyback ratio was -0.06%.

LAVA Therapeutics NV Shares Buyback Ratio % Historical Data

The historical data trend for LAVA Therapeutics NV's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Shares Buyback Ratio % Chart

LAVA Therapeutics NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
Get a 7-Day Free Trial -37.68 -1.67 -1.99 - -0.06

LAVA Therapeutics NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 -0.02 -0.01 -0.02

LAVA Therapeutics NV Shares Buyback Ratio % Calculation

LAVA Therapeutics NV's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(26.289 - 26.305) / 26.289
=-0.06%

LAVA Therapeutics NV's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Sep. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Sep. 2024 )
=(26.299 - 26.305) / 26.299
=-0.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LAVA Therapeutics NV Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Shares Buyback Ratio %
Comparable Companies
KZR OSTX GRCE PPCB OKUR NRXP DYAI ALGS BOLD ESLA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
Website
https://www.lavatherapeutics.com
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.